Jan and Tom Lewis Migraine Treatment Program, Department of Neurology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, USA.
Cerebrovascular and Hospital Neurology, Penrose Neuroscience, Colorado Springs, CO, USA.
Curr Neurol Neurosci Rep. 2020 Mar 18;20(4):7. doi: 10.1007/s11910-020-01030-w.
This article reviews treatment options for patients presenting with headache in the emergency department (ED) and for inpatients, including red flags and status migrainosus (SM).
Most patients presenting with headache in the ED will have migraine, but red flags must be reviewed to rule out secondary headaches. SM refractory to home treatment is a common reason for ED presentation or inpatient admission, but high-quality treatment evidence is lacking. Common treatments include intravenous fluids, anti-dopaminergic agents with diphenhydramine, steroids, divalproex, nonsteroidal anti-inflammatory drugs, intravenous dihydroergotamine, and nerve blocks. Other therapies (e.g., ketamine and lidocaine) are used with limited or inconsistent evidence. There is evidence for inpatient behavioral management therapy. This article details red flags to review in the workup of headache presentation in the ED and provides a step-wise approach to ED and inpatient management. However, more studies are needed to better optimize care.
本文综述了急诊科(ED)和住院患者头痛的治疗选择,包括警示症状和偏头痛持续状态(SM)。
大多数在 ED 就诊的头痛患者为偏头痛,但必须审查警示症状以排除继发性头痛。在家治疗无效的 SM 是 ED 就诊或住院的常见原因,但缺乏高质量的治疗证据。常见的治疗方法包括静脉补液、含苯海拉明的抗多巴胺药物、类固醇、丙戊酸钠、非甾体抗炎药、静脉二氢麦角胺和神经阻滞。其他疗法(如氯胺酮和利多卡因)的应用证据有限或不一致。有证据表明住院患者的行为管理治疗有效。本文详细介绍了 ED 头痛评估中需要审查的警示症状,并提供了 ED 和住院管理的逐步方法。然而,需要更多的研究来更好地优化治疗。